美国联合医疗 UTHR 深 沪
已收盘 10-02 16:00:00 美东时间
541.70
-29.680
-5.19%
华盛通- 最 高577.02
- 今 开570.00
- 成交量 111.79万股
- 最 低 541.27
- 昨 收 571.38
- 总市值 232.34亿
- 52周最高 609.35
- 市盈率 静 19.44
- 换手率 2.61%
- 52周最低 409.07
- 委 比 -36.47%
- 总股本 4289.07万
- 历史最高 609.35
- 量 比 0.85
- 振 幅 6.26%
- 历史最低 36.55
- 每 手 1
- 风险率 42.76%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅1654.39%！Ascendiant Capital上调NRX Pharmaceuticals(NRXP)目标价至50美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从49美元升至50美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从24美元升至25美元
10-02 08:33
Liquidia Stock Extends Slide Following US Court Ruling in Patent Dispute
Shares of Liquidia Corp (NASDAQ:LQDA) are sliding Thursday morning, extending a sell-off triggered by an adverse federal court patent ruling in its ongoing legal dispute with rival United Therapeutics. Here’s what investors need to know. Liquidia stock is feeling bearish pressure. Why is LQDA stock ...
10-02 00:03
This United Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Mizuho analyst Nick Setyan upgraded BJ’s Restaurants Inc (NASDAQ:BJRI) from Neutral to Outperform...
10-01 23:49
Progress Software, Nft And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around 200 points on Thursday. Shares of Progress Software Corp (NASDAQ:PRGS) fell sharply in pre-market trading after the company reported third-quarter financial results. Progress Software reported fiscal third-quarter revenu...
10-01 20:01
Why is Liquidia (LQDA) Stock Trending After Hours?
Liquidia Corp. (NASDAQ:LQDA) shares are trending on Wednesday night. Shares of the North Carolina-based biopharmaceutical company edged 0.13% higher to $30.30 in after-hours trading on Wednesday. In the regular session, LQDA closed at $30.26, down 57.19%, according to Benzinga Pro data. The stock ex...
10-01 11:29
Sagimet Biosciences stock rises after pricing $115M securities offering
Sagimet Biosciences (SGMT) said it priced an underwritten offering of 8.75M Series A common shares at $10 per share, or pre-funded warrants to purchase 2.75M shares at $9.9999 per warrant for certain ...
09-30 18:31
Liquidia Provides Update on Hatch-Waxman Litigation Tied to ‘327 Patent
A U.S. District Court ruled that two claims of United Therapeutics' '327 patent related to Liquidia's YUTREPIA (treprostinil) inhalation powder are valid and infringed. The remaining four claims were found invalid. Liquidia disagrees with the decision and plans to pursue appellate options, including removing PH-ILD from YUTREPIA's label. Potential remedies could include label changes or market restrictions. YUTREPIA, approved for PAH and PH-ILD, ...
09-30 17:20
美股大行评级 | Meta获4家机构齐升目标价，最高看至995美元！麦当劳遭6家机构下调，最低看至260美元
今日重点评级关注：Canaccord Genuity：维持Aurora Innovation"买入"评级，目标价从15美元升至17美元；摩根大通：维持皇家加勒比邮轮"超配"评级，目标价从345美元升至394美元
09-25 15:55
Goldman Sachs Initiates Coverage On United Therapeutics with Sell Rating, Announces Price Target of $321
Goldman Sachs analyst Andrea Newkirk initiates coverage on United Therapeutics (NASDAQ:UTHR) with a Sell rating and announces Price Target of $321.
09-24 21:44
United Therapeutics Announces New Accelerated Share Repurchase
An announcement from United Therapeutics ( ($UTHR) ) is now available. On Septe...
09-09 05:28
